Intermediate-Size Expanded Access Protocol (EAP) for LP352

Conditions: Dravet Syndrome; Lennox Gastaut Syndrome; Developmental and Epileptic Encephalopathies Interventions: Drug: LP352 Sponsors: Longboard Pharmaceuticals Available

Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials